S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

Actualizaciones en tiempo real para Advicenne SA [ADVIC.PA]

Bolsa: EURONEXT Industria: Biotechnology
Última actualización31 dic 1970 @ 19:00

0.00% 6.50

Live Chart Being Loaded With Signals

Commentary (31 dic 1970 @ 19:00):

Advicenne S.A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy...

Stats
Volumen de hoy 63 830.00
Volumen promedio 45 756.00
Capitalización de mercado 0.00
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -3.67
ATR14 €0 (0.00%)

Advicenne SA Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Advicenne SA Finanzas

Annual 2022
Ingresos: €2.94M
Beneficio Bruto: €1.83M (62.05 %)
EPS: €-1.160
FY 2022
Ingresos: €2.94M
Beneficio Bruto: €1.83M (62.05 %)
EPS: €-1.160
FY 2019
Ingresos: €2.00M
Beneficio Bruto: €-10.85M (-542.73 %)
EPS: €-1.680
FY 2018
Ingresos: €1.19M
Beneficio Bruto: €-7.27M (-610.76 %)
EPS: €-0.620

Financial Reports:

No articles found.

Advicenne SA

Advicenne S.A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy. The company also provides ADV6209, an oral liquid solution for children to reduce anxiety and to improve their immobility. Advicenne S.A. was founded in 2007 and is based in Paris, France.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico